The deal for the privately held U.K.-based biotechnology agency will assist bolster Novartis’s oncology capabilities.
Source link
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Related Posts
Suspect in arson Sam Altman home aimed to kill, warned extinction AI
OpenAI CEO Sam Altman attends an occasion to pitch AI for companies in Tokyo, Feb. 3, 2025. Kim Kyung-hoon |…
How a 2020 Rolex Collection Changed the Face of Watch Design
As the corporate that both invented or popularized the dive watch, the GMT watch, the primary waterproof watch, the primary…
Malicious Traffic Surges 245% Since Iran War Began
Malicious visitors has surged worldwide for the reason that Iran battle started, exposing rising dangers from coordinated assaults, reconnaissance, and…